Phototherapy is a widely used therapeutic modality for managing hyperbilirubinemia in neonates, a common condition that results in jaundice. While the benefits of phototherapy in reducing bilirubin levels are well-established, it is crucial to consider the potential risks, especially when it comes to the eyes of newborns. This has led to the implementation of eye shield phototherapy as a standard practice in neonatal care. Eye shield phototherapy employs specially designed shields to protect the infant's eyes, minimizing the risk of ocular complications while ensuring effective bilirubin reduction. International guidelines recommend the use of eye protection during phototherapy to minimize the potential harm to the eyes of neonates. Healthcare providers adhere to these guidelines to ensure the well-being of the infants under their care. Eye shield phototherapy is a crucial aspect of neonatal care, balancing the therapeutic benefits of phototherapy with the need to protect the delicate eyes of newborns. By incorporating these protective measures into standard protocols, healthcare providers can optimize the effectiveness of phototherapy while prioritizing the safety and comfort of the neonate.